A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bittoo Kanwar
Gilead Sciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
144 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Landeskrankenhaus Graz West
Graz, Austria
- Medizinische Universität Graz
Graz, Austria
- Lkh Innsbruck
Innsbruck, Austria
- Krankenhaus Der Elisabethinen Linz Gmbh
Linz, Austria
- Akh Der Stadt Wien
Vienna, Austria
- Wilhelminenspital Der Stadt Wien
Vienna, Austria
- Ziekenhuis Netwerk Antwerpen
Antwerp, Belgium
- Ucl Saint Luc
Brussels, Belgium
- Ulb Erasme
Brussels, Belgium
- Uz Antwerp
Edegem, Belgium
- Centre Hospitalier Universitaire Sart Tilman Liège
Liège, Belgium
- Beaujon Hospital
Clichy, France
- Henri Mondor Hospital
Créteil, France
- Hôpital de la Croix Rousse
Lyon, France
- Saint Joseph Hospital
Marseille, France
- Hôpital de I´archet 2, Service Hépatologie
Nice, France
- Centre Hospitalier Régional D'Orléans, Hôpital de la Source
Orléans, France
- Hôpital Cochin
Paris, France
- Groupe Hospitalier Du Haut Leveque
Pessac, France
- Centre Hospitalier Universitaire de Strasbourg - Hôpital Civil
Strasbourg, France
- Nancy University Hospital Center
Vandœuvre-lès-Nancy, France
- Charite University Medicine
Berlin, Germany
- Leber- Und Studienzentrum Am Checkpoint
Berlin, Germany
- University Hospital Bonn
Bonn, Germany
- University Hospital Essen
Essen, Germany
- Klinikum Der Johann Wolfgang Goethe-Universität
Frankfurt/M, Germany
- University Hospital Freiburg
Freiburg im Breisgau, Germany
- Asklepios Klinik Sankt Georg
Hamburg, Germany
- Medizinische Hochschule Hannover
Hanover, Germany
- University Hospital Heidelberg
Heidelberg, Germany
- University Hospital Leipzig
Leipzig, Germany
- Johannes Gutenberg University Hospital
Mainz, Germany
- Academisch Medisch Centrum Universiteit Van Amsterdam
Amsterdam, Netherlands
- Radaboud University Nijmegen Medical Centre (umc St Radboud)
Nijmegen, Netherlands
- Erasmus University Medical Center Rotterdam
Rotterdam, Netherlands
- Universitair Medisch Centrum Utrecht
Utrecht, Netherlands
- Wojewodzki Szpital Specjalistyczny Im. K. Dluskiego Oddzial Obserwacyjno-Zakazny
Bialystok, Poland
- Wojewodzki Szpital Obserwacyjno-Zakazny Im. Tadeusza Browicza Oddział Obserwacyjno-Zakazny
Bydgoszcz, Poland
- Szpital Specjalistyczny W Chorzowie
Chorzów, Poland
- Niepubliczny Zakład Opieki Zdrowotnej "pol-Sana-Med" Sp. Z O.O.
Czeladź, Poland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2010
- Primary completion
- 31 Jan 2013
- Completion
- 30 Sept 2013
- Last update posted
- 6 Feb 2014
- Registered enrollment
- 245
- Registry id
- NCT01271790
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.